This is an actively recruiting Phase 1/2 interventional trial with no posted results; it aims to evaluate safety and pharmacokinetics of shortened ampicillin dosing in preterm neonates but has not yet reported outcomes.
Reported
Estimated enrollment60
Primary outcome measureTotal plasma ampicillin concentration, coll…
Study phasePhase 1, Phase 2